Medium impact
KMAP BULLETIN: Opioid Use Disorder Rate Updates January 2026
Kansas Medicaid (KanCare)·Effective Jan 1, 2026
HCPCS G2216 is officially defined as "Take-home supply of injectable naloxone (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure." HCPCS G2216 is referenced in 1 tracked payer policy change from Kansas Medicaid (KanCare). For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G2216 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.